Medical and social costs after using financial incentives to improve medication adherence: results of a 1 year randomised controlled trial
Abstract Objective Offering a financial incentive (‘Money for Medication’) is effective in improving adherence to treatment with depot antipsychotic medications. We investigated the cost-effectiveness in terms of medical costs and judicial expenses of using financial incentives to improve adherence....
Main Authors: | Ernst L. Noordraven, André I. Wierdsma, Peter Blanken, Anthony F. T. Bloemendaal, Cornelis L. Mulder |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-09-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13104-018-3747-1 |
Similar Items
-
The effect of financial incentives on patients’ motivation for treatment: results of “Money for Medication,” a randomised controlled trial
by: Ernst L. Noordraven, et al.
Published: (2018-05-01) -
Ethical acceptability of offering financial incentives for taking antipsychotic depot medication: patients’ and clinicians’ perspectives after a 12-month randomized controlled trial
by: Ernst L. Noordraven, et al.
Published: (2017-08-01) -
Financial incentives to improve adherence to antipsychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial
by: Stefan Priebe, et al.
Published: (2016-09-01) -
Correlates of poor medication adherence in chronic psychotic disorders
by: Martha Sajatovic, et al.
Published: (2021-01-01) -
An interventional pilot of customized adherence enhancement combined with long-acting injectable antipsychotic medication (CAE-L) for poorly adherent patients with chronic psychotic disorder in Tanzania
by: Jessie Mbwambo, et al.
Published: (2022-01-01)